ANUHPHRNSEAnuh Pharma LimitedLowNeutral
Announced Tue, 29 Jul · 13:14 IST

Anuh Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 22, 2025

Board & Shareholder Meetings View source PDF

ANUHPHR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Anuh Pharma has called its 65th AGM for Friday, 22nd August 2025 at 4:00 PM at Nehru Centre, Worli, Mumbai. The main items include adopting FY25 audited financial results and declaring a final dividend of Rs. 1.50 per equity share (face value Rs. 5), which is a 30% payout on face value. Two directors — Mr. Bharat Nemchand Shah and Mr. Gaurav Satish Shah — are seeking re-appointment on retirement by rotation. The company is also seeking shareholder approval to ratify the Rs. 1.20 lakh remuneration of its Cost Auditor, appoint M/s. GHV & Co. as Secretarial Auditor for five years (FY26 to FY30), and revise the remuneration of Joint Managing Directors Mr. Ritesh Shah and Mr. Vivek Shah to a monthly CTC of Rs. 3.75 lakh (ceiling Rs. 5 lakh) plus up to 0.50% commission on net profit. Both JMDs are also being re-appointed for a fresh 5-year term starting January 8, 2026. E-voting runs from August 19 to August 21, 2025, with the cut-off date set as August 15, 2025.

Likely market impact

The Rs. 1.50 dividend rewards shareholders and signals steady cash generation, while the proposed pay hikes for the two promoter JMDs and their 5-year re-appointments tighten founder control and may draw governance scrutiny. Appointment of a new long-term secretarial auditor and cost auditor ratification are routine but improve compliance oversight.